Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news


breaking news - update

BASF sees synergies between new acquisition Pronova and Equateq

By Gareth MacDonald+

Last updated on 21-Jan-2013 at 10:41 GMT2013-01-21T10:41:43Z

BASF wins over Pronova shareholders
BASF wins over Pronova shareholders

BASF has had its offer for omega-3 API maker Pronova Biopharma accepted by 97.7 per cent of the Norwiegan firm’s shareholders.

The deal – which will see the German firm pay around €684m for Pronova – was finally accepted last week after a bidding process that saw the German chemicals firm increase its offer in response to resistance from minority shareholders.

A BASF spokesman told today that: “We are confident that this is a good investment.

This acquisition will create numerous synergies by combining BASF’s global customer reach and many years of experience with Pronova’s solid know-how and scientific expertise in the production of highly concentrated omega-3 fatty acids, with the technology portfolio of Equateq [now operating under the name BASF Pharma Callanish].”

He explained that the aim of the deal was to strengthen BASF’s portfolio and expand its position in the research and development and manufacturing of omega-3 fatty acids for pharmaceutical and consumer health products.

BASF will have an attractive technology portfolio for developing and manufacturing omega-3 fatty acids. Highly concentrated omega-3 fatty acids are a globally growing market, driven by an increasing consumer awareness of omega-3 fatty acid health benefits.”  

Pronova supplies GSK with the active pharmaceutical ingredient (API) for its heart pill Lovaza. BASF’s other omega-3 business – BASF Pharma Callanish -  is one of the firm’s for which Amarin is seeking US Food and Drug Administration (FDA) approval as a supplier for its rival product Vascepa .

Fatty acid synergies

Pronova gives BASF capacity. The firm operates two production facilities – one in Norway and one in Denmark – which are capable of producing 2,500 tons of pharmaceutical grade omega-3 a year and employs around 311 people.

This contrasts with BASF Callanish, which has a single production facility on the Isle of Lewis in Scotland .

The technology 'synergies' mentioned above are likely to involve the proprietary chromatographic separation methods in place at Callanish that - according to BASF - allow for more flexible blending and formulation of omega-3 fatty acids at exceptional purity levels.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars